Initial Prior Authorization with Quantity Limit Qsymia Weight Loss Management
Customize your policy alerts
Sign up for cvs_caremark Policy 794-C alerts
Get alerted when Policy 794-C changes without checking for updates manually.
Monitor payer policy activity
This policy governs initial and continuation prior authorization, dose escalation, and quantity limits for Qsymia (phentermine/topiramate extended-release) used with diet and physical activity for weight reduction or long-term maintenance in adults and patients aged 12 years and older who meet specified eligibility criteria.
No material clinical or coverage changes in this revision.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.